Clinical Trials Directory

Trials / Terminated

TerminatedNCT01475604

Impact of Noninvasive Targeted Pulsed Electromagnetic Field (tPEMF) on Opioid Use, Pain, and Joint Function Following Total Knee Arthroplasty

Impact of Noninvasive Targeted Pulsed Electromagnetic Field (tPEMF) on Opioid Use, Pain, and Joint Function Following Total Knee Arthroplasty: A Double-Blind, Randomized, Sham-controlled Trial

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Amp Orthopedics, Inc. · Industry
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effectiveness of pulsed radio frequency (PRF), a type of electromagnetic field treatment with the Ivivi Torino II for reducing post-operative narcotic use in patients recovering from Total Knee Arthroplasty.

Detailed description

Surgeons are continually looking for means to minimize postoperative pain following TKA in order to reduce or eliminate the need for opioid pain medications. Reductions in pain and edema along with improvements in range of motion encourage quicker recovery of joint function and normal activities. Pulsed radio frequency (PRF), a type of electromagnetic field treatment is proven to effectively modulate postoperative pain and edema in plastic surgery. Therefore, PRF has potential as an adjunct therapy for patients recovering from TKA. The purpose of the current double-blind, randomized, sham-controlled clinical trial is to determine the effectiveness and safety of the Ivivi Torino II, a device that delivers pulsed radio frequency (PRF), a type of electromagnetic field treatment, in patients recovering from TKA for treatment of severe knee OA.

Conditions

Interventions

TypeNameDescription
DEVICEIvivi Torino IITargeted pulsed electromagnetic field treatment for 4 weeks post-surgery
DEVICEIvivi Torino IISham treatment for 4 weeks post-surgery

Timeline

Start date
2011-11-01
Primary completion
2012-07-01
Completion
2012-07-01
First posted
2011-11-21
Last updated
2012-07-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01475604. Inclusion in this directory is not an endorsement.